Novo Nordisk slides while Moderna pops: Tale of two pharma stocks

Novo Nordisk Nouvelles

Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
Moderna,Earnings Reports,Pharmaceutical Stocks

Pharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall...

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 43 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 63%

Galen Weston calls Loblaw boycott 'misguided criticism', says grocer not responsible for higher prices

"Their frustration is understandable, but this kind of expectation betrays a misunderstanding of what's actually driving food prices higher in this country."This dividend stock is near 52-week highs, but still down from all-time highs, with a highly valuable P/E ratio you won't want to miss. The post 1 Magnificent Dividend Stock That’s Down 21% and Trading at a Once-in-a-Decade Valuation appeared first on The Motley Fool Canada.The Canadian dollar strengthened against its U.S.

-- Traders on Wall Street cheered on Wednesday when Federal Reserve Chair Jerome Powell signaled he didn’t see oncoming interest-rate hikes despite inflationary pressures. The celebration didn’t last long.Most Read from BloombergUS and Saudis Near Defense Pact Meant to Reshape Middle EastJerome Powell Offered Markets a Reprieve.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

YahooFinanceCA /  🏆 47. in BE
 

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drugNovo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drugNovo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly
Lire la suite »



Render Time: 2025-01-12 20:32:26